Premium
Kyverna Therapeutics Inc (KYTX)
NASDAQ
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Kyverna Therapeutics is a cell therapy company engineering a new class of therapies for autoimmune and inflammatory diseases. The Kyverna therapeutic platform combines advanced T-cell engineering and synthetic biology technologies to suppress and eliminate the autoreactive immune cells at the origin... Kyverna Therapeutics is a cell therapy company engineering a new class of therapies for autoimmune and inflammatory diseases. The Kyverna therapeutic platform combines advanced T-cell engineering and synthetic biology technologies to suppress and eliminate the autoreactive immune cells at the origin of autoimmune and inflammatory diseases. Kyverna's pipeline includes next-generation chimeric antigen receptor T-cell (CAR T) therapies in both autologous and allogeneic formats with properties well suited for use in B cell-driven autoimmune diseases. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.22 | -7.18954248366 | 3.06 | 3.2397 | 2.83 | 284405 | 2.94155083 | CS |
| 4 | -0.53 | -15.7270029674 | 3.37 | 4.0593 | 2.645 | 480506 | 3.25183282 | CS |
| 12 | -2.65 | -48.2695810565 | 5.49 | 7.2 | 2.645 | 397868 | 3.87332202 | CS |
| 26 | -4.68 | -62.2340425532 | 7.52 | 8.78 | 2.645 | 363481 | 4.85890565 | CS |
| 52 | -25.17 | -89.8607640129 | 28.01 | 30.6 | 2.645 | 433656 | 10.29323548 | CS |
| 156 | -31.41 | -91.7080291971 | 34.25 | 35.01 | 2.645 | 441660 | 11.24373796 | CS |
| 260 | -31.41 | -91.7080291971 | 34.25 | 35.01 | 2.645 | 441660 | 11.24373796 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
